Clinical Trial: Clinical research on the application of targeted DDR2 positron emission tomography (PET) probe imaging agents in the diagnosis of interstitial lung disease (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on the application of targeted DDR2 positron emission tomography (PET) probe imaging agents in the diagnosis of interstitial lung disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130299

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Guilin Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338374

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical research on the application of targeted DDR2 positron emission tomography (PET) probe imaging agents in the diagnosis of interstitial lung disease (China)